Anaerobic biotechnology for pharmaceutical wastewater treatment

The wastewater generated from the pharmaceutical industry contain high organic load and the treatment are primarily carried out using two major types of biological methods; aerobic and anaerobic. However, due to high strength, it is infeasible to treat some pharmaceutical wastewater using aerobic bi...

Full description

Saved in:
Bibliographic Details
Main Authors: Chelliapan, Shreeshivadasan, Sallis, Paul J.
Format: Article
Published: RJPBCS 2013
Subjects:
Online Access:http://eprints.utm.my/id/eprint/49185/
https://www.rjpbcs.com/
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.utm.49185
record_format eprints
spelling my.utm.491852018-10-21T04:33:19Z http://eprints.utm.my/id/eprint/49185/ Anaerobic biotechnology for pharmaceutical wastewater treatment Chelliapan, Shreeshivadasan Sallis, Paul J. QD Chemistry The wastewater generated from the pharmaceutical industry contain high organic load and the treatment are primarily carried out using two major types of biological methods; aerobic and anaerobic. However, due to high strength, it is infeasible to treat some pharmaceutical wastewater using aerobic biological processes. As an alternative, an anaerobic process is preferred to remove high strength organic matter. Anaerobic wastewater treatment is considered as the most cost effective solution for organically polluted industrial waste streams. In particular the development of the high rate systems, in which hydraulic retention times (HRT) are uncoupled from solids retention times (SRT), has led to a worldwide acceptance of anaerobic wastewater treatment. In this paper, a brief literature on anaerobic digestion, anaerobic reactor technology and existing anaerobic treatment of pharmaceutical wastewater are presented. A case study of a laboratory investigation into the treatment of pharmaceutical wastewater containing antibiotics in an Up-Flow Anaerobic Stage Reactor (UASR) was also given. Specifically, it was determined whether a UASR could be used as a pre-treatment system at an existing pharmaceutical production plant. Results from this study showed a chemical oxygen demand (COD) reduction of 70 - 75% was achieved in the UASR RJPBCS 2013 Article PeerReviewed Chelliapan, Shreeshivadasan and Sallis, Paul J. (2013) Anaerobic biotechnology for pharmaceutical wastewater treatment. Research Journal of Pharmaceutical, Biological and Chemical Sciences, 4 (4). pp. 1255-1261. ISSN 0975-8585 https://www.rjpbcs.com/
institution Universiti Teknologi Malaysia
building UTM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Teknologi Malaysia
content_source UTM Institutional Repository
url_provider http://eprints.utm.my/
topic QD Chemistry
spellingShingle QD Chemistry
Chelliapan, Shreeshivadasan
Sallis, Paul J.
Anaerobic biotechnology for pharmaceutical wastewater treatment
description The wastewater generated from the pharmaceutical industry contain high organic load and the treatment are primarily carried out using two major types of biological methods; aerobic and anaerobic. However, due to high strength, it is infeasible to treat some pharmaceutical wastewater using aerobic biological processes. As an alternative, an anaerobic process is preferred to remove high strength organic matter. Anaerobic wastewater treatment is considered as the most cost effective solution for organically polluted industrial waste streams. In particular the development of the high rate systems, in which hydraulic retention times (HRT) are uncoupled from solids retention times (SRT), has led to a worldwide acceptance of anaerobic wastewater treatment. In this paper, a brief literature on anaerobic digestion, anaerobic reactor technology and existing anaerobic treatment of pharmaceutical wastewater are presented. A case study of a laboratory investigation into the treatment of pharmaceutical wastewater containing antibiotics in an Up-Flow Anaerobic Stage Reactor (UASR) was also given. Specifically, it was determined whether a UASR could be used as a pre-treatment system at an existing pharmaceutical production plant. Results from this study showed a chemical oxygen demand (COD) reduction of 70 - 75% was achieved in the UASR
format Article
author Chelliapan, Shreeshivadasan
Sallis, Paul J.
author_facet Chelliapan, Shreeshivadasan
Sallis, Paul J.
author_sort Chelliapan, Shreeshivadasan
title Anaerobic biotechnology for pharmaceutical wastewater treatment
title_short Anaerobic biotechnology for pharmaceutical wastewater treatment
title_full Anaerobic biotechnology for pharmaceutical wastewater treatment
title_fullStr Anaerobic biotechnology for pharmaceutical wastewater treatment
title_full_unstemmed Anaerobic biotechnology for pharmaceutical wastewater treatment
title_sort anaerobic biotechnology for pharmaceutical wastewater treatment
publisher RJPBCS
publishDate 2013
url http://eprints.utm.my/id/eprint/49185/
https://www.rjpbcs.com/
_version_ 1643652721515954176
score 13.209306